Analytical Data
-
基因名
esaA
- Application
-
别名
esaA；Type VII secretion system accessory factor EsaA
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0C049
-
表达区间
483-821aa
-
氨基酸序列
DPHFNFEGDIKINGKKYDIKDQSVQLDTSNKEYKVEVNGVAKLKKDAEKDFLKDKTMHLQLLFGQANRQDEPNDKKATSVVDVTLNHNLDGRLSKDALSQQLSALSRFDAHYKMYTDTKGREDKPFDNKRLIDMMVDQVINDMESFKDDKVAVLHQIDSMEENSDKLIDDILNNKKNTTKNKEDISKLIDQLENVKKTFAEEPQEPKIDKGKNDEFNTMSSNLDKEISRISEKSTQLLSDTQESKSIADSVSGQLNQVDNNVNKLHATGRALGVRANDLNRQMAKNDKDNELFAKEFKKVLQNSKDGDRQNQALKAFMSNPVQKKNLENVLANNGNTDV
-
分子量
46.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human TRAF2 Protein，His
Cat：PA2000-635DB
Recombinant Human LRRC49 Protein，GST
Cat：PA2000-9075
Protein Description
The esaA gene, a crucial component in the pathogenesis of certain bacteria, particularly in the context of infectious diseases, has garnered significant interest among researchers. This gene is associated with the production of virulence factors that enable bacteria to evade host immune responses and establish infections. Studies have demonstrated that esaA plays a vital role in biofilm formation, which is a key strategy for bacterial survival and persistence in hostile environments. The recombinant protein derived from esaA serves as a valuable tool for understanding its functional mechanisms and interactions within the host. Additionally, the expression and characterization of esaA recombinant protein provide insights into potential therapeutic targets and the development of vaccines aimed at combating bacterial infections. The ongoing research into esaA and its protein products not only enhances our comprehension of bacterial biology but also underscores the importance of addressing infectious diseases through innovative biotechnological approaches. Furthermore, the advancement in recombinant DNA technology has paved the way for the efficient production of esaA protein, facilitating the exploration of its structural and functional properties, which could lead to new strategies for intervention and treatment in infectious diseases caused by pathogenic bacteria.
